Subtype
Malignant Reproductive System Neoplasm
CI-CAN-00001172Explore in graph →
2,804 active trials38 approved drugs186 evidence items
- NCIt
- C36076
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001172Explore in graph →
Clinical trials
12,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,473)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00257829 | Improving Tumor Oxygenation in Cervical Cancer | withdrawn | Phase 2 | 0 | University of California, IrvineOTHER | 0 | Dec 3, 2018 | clinicaltrials |
| NCT02530606 | Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer | withdrawn | N/A | 0 | Stanford UniversityOTHER | 1 | Nov 28, 2018 | clinicaltrials |
| NCT00963300 |
| MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy |
| withdrawn |
| N/A |
| 0 |
| University of Texas Southwestern Medical CenterOTHER |
| 0 |
| Nov 26, 2018 |
| clinicaltrials |
| NCT03296124 | Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32)(PRX32) | withdrawn | — | 0 | University of FloridaOTHER | 1 | Nov 16, 2018 | clinicaltrials |
| NCT02470819 | Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer | withdrawn | N/A | 0 | Avera McKennan Hospital & University Health CenterOTHER | 1 | Nov 7, 2018 | clinicaltrials |
| NCT03220009 | Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Oct 3, 2018 | clinicaltrials |
| NCT00003821 | Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer | withdrawn | Phase 2 | 0 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Sep 18, 2018 | clinicaltrials |
| NCT00005645 | ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment | withdrawn | Phase 2 | 0 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Sep 18, 2018 | clinicaltrials |
| NCT02836028 | A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer | withdrawn | Phase 2 | 0 | PfizerINDUSTRY | 0 | Sep 18, 2018 | clinicaltrials |
| NCT03014973 | Castration-resistant Prostate Cancer and Intra-prostatic Hormonal Status(HORM) | withdrawn | N/A | 0 | Hopital FochOTHER | 1 | Sep 13, 2018 | clinicaltrials |
| NCT03212807 | Study Of Durvalumab and Lenalidomide In R/R EBV Associated DLBCL Subtypes, Primary CNS And Testicular DLBCL(DuRIANS) | withdrawn | Phase 2 | 0 | Singapore General HospitalOTHER | 1 | Sep 13, 2018 | clinicaltrials |
| NCT00562341 | Effect of Lap-Band Induced Weight Loss on Serum PSA Levels | withdrawn | — | 0 | Maimonides Medical CenterOTHER | 1 | Aug 23, 2018 | clinicaltrials |
| NCT00922818 | Study of Anatomic Nerve Sparing Radical Perineal Prostatectomy(RPP) | withdrawn | — | 0 | Maimonides Medical CenterOTHER | 1 | Aug 20, 2018 | clinicaltrials |
| NCT02179762 | Vigorous or Moderate Exercise in Enhancing Active Surveillance in Patients With Localized Prostate Cancer(EASE) | withdrawn | N/A | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Aug 9, 2018 | clinicaltrials |
| NCT03465345 | Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients | withdrawn | Phase 1 | 0 | Medical University of South CarolinaOTHER | 1 | Aug 3, 2018 | clinicaltrials |
| NCT02053311 | Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents | withdrawn | Phase 3 | 0 | Swiss Cancer InstituteOTHER | 1 | Jul 30, 2018 | clinicaltrials |
| NCT02252978 | Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy | withdrawn | Phase 2 | 0 | Wake Forest University Health SciencesOTHER | 1 | Jul 5, 2018 | clinicaltrials |
| NCT00996749 | Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 0 | Jul 3, 2018 | clinicaltrials |
| NCT01328067 | Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids | withdrawn | N/A | 0 | InSightecINDUSTRY | 1 | Jun 15, 2018 | clinicaltrials |
| NCT02878980 | An Exercise Intervention Trial to Reduce Symptoms & Improve Clinical Outcomes of Platinum-Based Treatment in Ovarian Cancer Patients | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 1 | Jun 15, 2018 | clinicaltrials |
| NCT02872519 | PET Imaging of Ovarian Carcinoma With 18F-FSPG | withdrawn | Early Phase 1 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Jun 6, 2018 | clinicaltrials |
| NCT02833506 | Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | withdrawn | Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 1 | May 1, 2018 | clinicaltrials |
| NCT02206724 | Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer | withdrawn | N/A | 0 | Sharp HealthCareOTHER | 1 | Apr 20, 2018 | clinicaltrials |
| NCT01188408 | Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | INSYS Therapeutics IncINDUSTRY | 1 | Mar 12, 2018 | clinicaltrials |
| NCT00588263 | Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer | withdrawn | — | 0 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT02546427 | Hypofractionated Whole Pelvic Radiotherapy of the Prostate | withdrawn | N/A | 0 | Albert J. ChangOTHER | 0 | Feb 12, 2018 | clinicaltrials |
| NCT02736435 | Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound | withdrawn | Phase 3 | 0 | Thunder Bay Regional Health Research InstituteOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT00003534 | Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer | withdrawn | Phase 2 | 0 | Burzynski Research InstituteOTHER | 1 | Jan 31, 2018 | clinicaltrials |
| NCT00769990 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | withdrawn | Phase 1 / Phase 2 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 0 | Dec 13, 2017 | clinicaltrials |
| NCT01260909 | Real-Time MV/kV Image Guided Radiation Therapy | withdrawn | — | 0 | Stanford UniversityOTHER | 0 | Dec 2, 2017 | clinicaltrials |
| NCT00428194 | Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer | withdrawn | Phase 1 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00562185 | Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian Cancer | withdrawn | Phase 1 / Phase 2 | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | Nov 20, 2017 | clinicaltrials |
| NCT02793219 | Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT02793765 | Docetaxel Followed by Provenge in Metastatic Prostate Cancer | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Oct 30, 2017 | clinicaltrials |
| NCT02232672 | Choline PET/CT vs. MeAIB PET/CT in Prostate Cancer | withdrawn | N/A | 0 | Odense University HospitalOTHER | 1 | Oct 13, 2017 | clinicaltrials |
| NCT03032614 | Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients | withdrawn | Phase 2 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 0 | Oct 10, 2017 | clinicaltrials |
| NCT03007771 | Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Oct 6, 2017 | clinicaltrials |
| NCT03173807 | Prostate Nutrition and Exercise STudy (ProNEST)(ProNEST) | withdrawn | N/A | 0 | University of PittsburghOTHER | 0 | Oct 6, 2017 | clinicaltrials |
| NCT00600210 | Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer | withdrawn | Phase 2 | 0 | Leo W. Jenkins Cancer CenterOTHER | 1 | Aug 23, 2017 | clinicaltrials |
| NCT02810886 | Prospective Evaluation of 68Ga-PSMA PET-CT for Recurrence Detection of Prostate Cancer and Its Impact on Patient Management(ProsPERo) | withdrawn | Phase 2 | 0 | Jules Bordet InstituteOTHER | 0 | Aug 22, 2017 | clinicaltrials |
| NCT00900081 | Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer | withdrawn | — | 0 | Wake Forest University Health SciencesOTHER | 0 | Aug 1, 2017 | clinicaltrials |
| NCT00003622 | Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | withdrawn | Phase 2 | 0 | James AhlgrenOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT00003865 | Toremifene in Treating Patients With Ovarian Cancer | withdrawn | Phase 2 | 0 | George Washington UniversityOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT01176500 | A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors | withdrawn | Phase 1 / Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01386502 | CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT00603460 | DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | University of PennsylvaniaOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT02704650 | Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids | withdrawn | N/A | 0 | Shaare Zedek Medical CenterOTHER | 0 | Apr 27, 2017 | clinicaltrials |
| NCT00937417 | S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Apr 24, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Dec 3, 2018source: clinicaltrials